- Home
- NKTX vs COYA Comparison
NKTX vs COYA Comparison
Compare NKTX & COYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NKTX
- COYA
- Stock Information
- Founded
- NKTX 2015
- COYA 2020
- Country
- NKTX United States
- COYA United States
- Employees
- NKTX N/A
- COYA N/A
- Industry
- NKTX Biotechnology: Pharmaceutical Preparations
- COYA Biotechnology: Pharmaceutical Preparations
- Sector
- NKTX Health Care
- COYA Health Care
- Exchange
- NKTX Nasdaq
- COYA Nasdaq
- Market Cap
- NKTX 123.5M
- COYA 99.8M
- IPO Year
- NKTX 2020
- COYA 2022
- Fundamental
- Price
- NKTX $1.80
- COYA $6.13
- Analyst Decision
- NKTX Strong Buy
- COYA Strong Buy
- Analyst Count
- NKTX 6
- COYA 4
- Target Price
- NKTX $14.40
- COYA $16.50
- AVG Volume (30 Days)
- NKTX 434.5K
- COYA 71.0K
- Earning Date
- NKTX 08-12-2025
- COYA 08-11-2025
- Dividend Yield
- NKTX N/A
- COYA N/A
- EPS Growth
- NKTX N/A
- COYA N/A
- EPS
- NKTX N/A
- COYA N/A
- Revenue
- NKTX N/A
- COYA $3,685,107.00
- Revenue This Year
- NKTX N/A
- COYA $106.97
- Revenue Next Year
- NKTX N/A
- COYA N/A
- P/E Ratio
- NKTX N/A
- COYA N/A
- Revenue Growth
- NKTX N/A
- COYA N/A
- 52 Week Low
- NKTX $1.31
- COYA $4.65
- 52 Week High
- NKTX $8.23
- COYA $10.24
- Technical
- Relative Strength Index (RSI)
- NKTX 51.45
- COYA 57.80
- Support Level
- NKTX $1.68
- COYA $5.97
- Resistance Level
- NKTX $1.84
- COYA $6.45
- Average True Range (ATR)
- NKTX 0.08
- COYA 0.38
- MACD
- NKTX 0.01
- COYA 0.06
- Stochastic Oscillator
- NKTX 80.95
- COYA 69.05
About NKTX Nkarta Inc.
Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.
About COYA Coya Therapeutics Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.